V

Vor Biopharma Inc
NASDAQ:VOR

Watchlist Manager
Vor Biopharma Inc
NASDAQ:VOR
Watchlist
Price: 14.26 USD -9.86% Market Closed
Market Cap: 232.2m USD

Net Margin
Vor Biopharma Inc

0%
Current
0%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-2.4B
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Vor Biopharma Inc
Glance View

Market Cap
232.2m USD
Industry
Biotechnology

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. The company is headquartered in Cambridge, Massachusetts and currently employs 135 full-time employees. The company went IPO on 2021-02-05. The firm is engaged in combining a novel patient engineering approach with targeted therapies to provide solutions for patients suffering from hematological malignancies. Its proprietary platform leverages expertise in hematopoietic stem cell (HSC) biology, genome engineering and targeted therapy development to genetically modify HSCs to remove surface targets expressed by cancer cells. VOR33 is the lead product candidate consisting of genome-edited hematopoietic stem and progenitor cells that have been engineered to lack the CD33 protein. The company is designed to replace the standard of care in transplant settings for patients suffering from acute myeloid leukemia (AML) and other blood cancers. VBP101 is a Phase I/II a multicenter, open-label, first-in-human study of VOR33 in participants with AML. The company offers VCAR33 programs that are chimeric antigen receptor T (CAR-T) cell therapy candidates designed to target CD33.

VOR Intrinsic Value
Not Available
V
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-2.4B
/
Revenue
0
What is the Net Margin of Vor Biopharma Inc?

Based on Vor Biopharma Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top